US$ 22.40
l carnitine ιδιοτητεσ Ακετυλο-L-καρνιτίνη: Απαραίτητη για συντήρηση, προστασία
Description
8A and B, the SA, MSNs-ss-OH, and MSNs-ss-OH and SA treatments resulted in increases in the SA and JA contents, ranging from 27.90 to 59.65% and 48.14116.11%, respectively

Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome

Zhang XD, Zhang ZY, Zhao MP, Zhang XT, Wang N, Gao HZ, et al

doi: 10.1371/journal.pone.0020386
